Tsuda H, Sakata T, Masui T, Imaida K, Ito N
Carcinogenesis. 1984 Apr;5(4):525-31. doi: 10.1093/carcin/5.4.525.
Studies were made on the effects of butylated hydroxyanisole (BHA), ethoxyquin (EQ) and acetaminophen (AAP) on the induction of neoplastic lesions in the liver and kidney of rats initiated by N-ethyl-N-hydroxyethylnitrosamine (EHEN). The number and area of histochemical gamma-glutamyltranspeptidase-positive (gamma-GT+) foci per unit area of liver section in rats given BHA, EQ or AAP were significantly less than in rats given EHEN alone. Similarly, the number of hyperplastic nodules (HN) in groups given BHA or AAP and their area in groups given BHA, EQ or AAP were significantly less than in control groups. Induction of hepatocellular carcinoma (HCC) was also clearly inhibited by these three chemicals. No liver lesions were found in any animals given BHA, EQ or AAP orally without EHEN. In contrast, the incidence and quantitative values of preneoplastic lesions and renal cell adenoma were significantly increased in groups given BHA, EQ or AAP. The results clearly demonstrated that BHA, EQ and AAP inhibited the development of gamma-GT+ foci, HN and HCC, whereas they enhanced the appearance of preneoplastic and neoplastic lesions in the kidney.
研究了丁基羟基茴香醚(BHA)、乙氧喹(EQ)和对乙酰氨基酚(AAP)对N-乙基-N-羟乙基亚硝胺(EHEN)引发的大鼠肝脏和肾脏肿瘤性病变诱导作用的影响。给予BHA、EQ或AAP的大鼠肝脏切片单位面积内组织化学γ-谷氨酰转肽酶阳性(γ-GT+)灶的数量和面积显著少于仅给予EHEN的大鼠。同样,给予BHA或AAP组的增生性结节(HN)数量以及给予BHA、EQ或AAP组的HN面积均显著少于对照组。这三种化学物质对肝细胞癌(HCC)的诱导也有明显抑制作用。在未给予EHEN而口服BHA、EQ或AAP的任何动物中均未发现肝脏病变。相反,给予BHA、EQ或AAP组的癌前病变和肾细胞腺瘤的发生率及定量值显著增加。结果清楚地表明,BHA、EQ和AAP抑制了γ-GT+灶、HN和HCC的发展,而它们却增强了肾脏中癌前和肿瘤性病变的出现。